Market Place
Sourcing Support
Insmed Reports Q3 2024 Results and Business Update
31 Oct 2024 //
PR NEWSWIRE
Insmed Reports Q2 2024 Results And Provides Business Update
08 Aug 2024 //
PR NEWSWIRE
Insmed Presents ARIKAYCE NTM PRO, Microbiology Data At ATS
20 May 2024 //
PR NEWSWIRE
Enforcement Report - Week of February 22, 2023
22 Feb 2023 //
FDA
Teva`s troubled plant seen to create injectable drug shortages
24 May 2022 //
FIERCEPHARMA
Hearing on anti-dumping investigation on raw material to be held on August 20
14 Aug 2021 //
PHARMABIZ
Insmed Initiates Frontline Clinical Trial Program for ARIKAYCE®
04 Jan 2021 //
PRNEWSWIRE
Valeo announces Amikacin approval in CANADA & U.S. launch of Ethacrynate Sodium
12 Nov 2020 //
PRNEWSWIRE
EMA: Thumbs up for 11, down for 2 new medicines
25 Jul 2020 //
RAPS
New NTM Treatment Guidelines Recommend Insmed`s ARIKAYCE®
07 Jul 2020 //
PRNEWSWIRE
PvPI releases list of 9 drugs with previously unknown AEs; list
27 Mar 2019 //
PHARMABIZ
FDA`s Record Year: A Look at 2018 New Drug Approvals
08 Jan 2019 //
RAPS
PANTHERx Selected by Insmed to Distribute ARIKAYCE® (amikacin)
17 Dec 2018 //
PR NEWSWIRE
Insmed`s treatment-resistant lung disease drug gets FDA approval
29 Sep 2018 //
REUTERS
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.